Sign Up Today and Learn More About Octave Stock
Invest in or calculate the value of your shares in Octave or other pre-IPO companies through EquityZen's platform.
Octave Stock (OCTV)
Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.
About Octave Stock
Founded
2014
Headquarters
Menlo Park, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Octave Press Mentions
Stay in the know about the latest news on Octave
Octave Commercially Launches a First-in-Class Precision Care Solution for Multiple Sclerosis
businesswire • Nov 28, 2022
Octave Presents Data at the CMSC 2022 Annual Meeting Showing its Multiple Sclerosis Disease Activity Biomarker Test Produces Clinical Practice Population Insights
businesswire • Nov 28, 2022
Precision care solutions for multiple sclerosis
nature • Nov 28, 2022
Octave Bioscience Secures $32 Million Series B Financing
businesswire • Dec 17, 2020
Octave Bioscience Secures $14M in Series A Financing
finsmes • Jul 17, 2018
Octave Management
Leadership team at Octave
Founder and CEO
William Hagstrom
COO and Co-Founder
Melinda Thomas
Join now and verify your accreditation status to gain access to:
- Octave current valuation
- Octave stock price
- Available deals in Octave and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Octave Stock
How to invest in Octave stock?
Accredited investors can buy pre-IPO stock in companies like Octave through EquityZen funds. These investments are made available by existing Octave shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Octave stock?
Shareholders can sell their Octave stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
